Actinomycin D, also known generically as dactinomycin, was approved by the US FDA on December 10,1964 and launched by Merck, Sharpe and Dohme under the trade name Cosmegen.
Actinomycin D was approved by the US FDA on December 10,1964. Actinomycin D was also known generically as dactinomycin. Actinomycin D was launched by Merck, Sharpe and Dohme under the trade name Cosmegen. Actinomycin D was also known generically as dactinomycin.